Coland Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other
companies in this sector in China:
Shanghai Fudan Forward S&T Co Ltd
sales of 670.57 million Chinese Renmimbi [US$101.31 million]
of which 56%
Zhejiang Starry Pharmaceutical Co Ltd
(672.75 million Chinese Renmimbi [US$101.64 million]
of which 99%
was Pharmaceuticals Industry), and
Ginwa Enterprise Group Inc.
(666.08 million Chinese Renmimbi [US$100.63 million]
of which 73%
was Pharmaceutical Industry).
Coland Holdings Limited reported sales of 675.24 million Chinese Renmimbi (US$102.01 million)
December of 2016.
increase of 26.8%
versus 2015, when the company's sales were 532.41 million Chinese Renmimbi.
Sales at Coland Holdings Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 105%).